http://news.vumc.org/2023/02/09/mark-...

A recording of the live stream from Vanderbilt University Medical Center on March 23, 2023.

Mark Cuban discusses how his Cost Plus Drug Company is innovating to lower prescription drug prices in America.

The discussion explores implications of the Journal of Urology paper that shows Cuban’s new drug company could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on the nine most popular urological drugs. The study was authored by Talwar and Sam S. Chang, MD, MBA, Patricia and Rodes Hart Endowed Professor of Urologic Surgery and VUMC Chief Surgical Officer, Vanderbilt Ingram Cancer Center.

Stacie Dusetzina, PhD, Professor of Health Policy at Vanderbilt University Medical Center is also featured.